Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,058
Sort by:
Biometric System Market with COVID-19 Impact by Authentication Type (Single-Factor: Fingerprint, Iris, Face, Voice; Multi-Factor), Offering (Hardware, Software), Type (Contact-based, Contactless, Hybrid), Vertical, and Region - Global Forecast to 2025
US$ 4,950.00
... to the biometrics system market. The report provides an overall view of the market including illustrative segmentation, analysis, and forecast for the biometrics system market based on authentication type, application ...
November 2020
207 pages
Cell Therapy Technologies Market by Product (Consumables, Equipment (Single-Use Equipment, Other Equipment), Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Research Institutes) - Global Forecast to 2025
US$ 4,950.00
... the largest share of the cell therapy instruments market. The rising adoption of human cells over animal cells for cell therapeutics research, technological advancements, and the rising ...
October 2020
168 pages
Scaffold Technology Market Size, Share & Trends Analysis Report By Type (Hydrogels, Nanofiber-based Scaffolds), By Application, By Disease Type, By End Use, By Region, And Segment Forecasts, 2020 - 2027
US$ 5,950.00
The global scaffold technology market is anticipated to reach USD 1.5 billion by 2024, according to a new report by Grand View Research, Inc.Evolution of scaffold technology, which facilitates the transplantation ...
October 2020
190 pages
Biomimetic Materials: Global Markets
US$ 5,500.00
Report : This report forecasts the size of the market in current U.S. dollars for biomimetic materials, in value terms from 2019 through 2025. It estimates and forecasts the market size or output, cla...
October 2020
140 pages
Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region - Global Forecast to 2025
US$ 4,950.00
... players in the primary cells market Market Development: Comprehensive information about emerging markets. This report analyses the market for various primary cells types across geographies Market Diversification: Exhaustive information ...
October 2020
176 pages
Generics Global Industry Guide 2015-2024
US$ 1,495.00
Generics Global Industry Guide 2013-2022 SUMMARY Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and ...
September 2020
273 pages
Generics BRIC (Brazil, Russia, India, China) Industry Guide 2015-2024
US$ 995.00
Generics BRIC (Brazil, Russia, India, China) Industry Guide 2013-2022 SUMMARY The BRIC Generics industry profile provides top-line qualitative and quantitative ... growth prospects of the BRIC generics market with five year forecasts by both value and volume Compares data from Brazil, Russia, India, and China, ...
September 2020
127 pages
Generics Global Group of Eight (G8) Industry Guide 2015-2024
US$ 1,495.00
Generics Global Group of Eight (G8) Industry Guide 2013-2022 SUMMARY The G8 Generics industry profile provides top-line qualitative and quantitative ... $25,218.0 and $17,343.3 million, respectively. The US is expected to lead the generics industry in the G8 nations with a value of $1,30,127.0 million in 2016, ...
September 2020
182 pages
Generics Global Industry Almanac 2015-2024
US$ 2,995.00
... Almanac 2013-2022 SUMMARY Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013 ... ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration ...
September 2020
482 pages
Generics North America (NAFTA) Industry Guide 2015-2024
US$ 795.00
... North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The generics industry ... within the NAFTA countries ...
September 2020
75 pages
Generics Top 5 Emerging Markets Industry Guide 2015-2024
US$ 995.00
Generics Top 5 Emerging Markets Industry Guide 2013-2022 SUMMARY The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market ... the emerging five generics market Leading company profiles reveal details of key generics market players’ emerging five ...
September 2020
139 pages
Contract Biomanufacturing Services Global Market - Forecast to 2028
US$ 4,950.00
... pipeline and as contract manufacturer for other pharmaceutical and biopharmaceutical companies. Contract manufacturing services are mainly benefitting ... giving an opportunity for the CMOs to gain market presence. The contract biomanufacturing global market is dominated by North American region commanded ...
September 2020
279 pages
Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding, Major Deals, 35 Company Profiles and Recent Developments - Forecast to 2027
US$ 2,690.00
The global liquid biopsy market is expected to reach nearly US$ 8.2 Billion by 2027. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need f...
September 2020
472 pages
Monoclonal Antibody Markets in China
US$ 4,000.00
China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
September 2020
219 pages
Monoclonal Antibody Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Monoclonal Antibody industry forecasts. In the two past decades, the ... -term forecasts through 2022 and 2027 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
September 2020
92 pages
Biotechnology Products Companies in China
US$ 1,800.00
This study focuses on China’s Biotechnology Products industry assessments and company profiles. In the two past decades, the industry has been ... consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing ...
September 2020
147 pages
Monoclonal Antibody Companies in China
US$ 1,800.00
This study focuses on China’s Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
September 2020
73 pages
Biotechnology Products Industry Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Biotechnology Products industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of ... to develop their own brand name products. This new study focuses on industry trends and forecasts with historical data (2007, 2012 ...
September 2020
180 pages
Global Biotech Partnering Terms and Agreements 2016-2020
US$ 3,495.00
SUMMARY Global Biotech Partnering Terms and Agreements 2014 to 2019 report provides a detailed understanding and analysis of how and why companies enter Biotech partnering deals DESCRIPTION Global Biotech Partnering Terms and Agreements 2014 ...
September 2020
2900 pages
Stem Cell Umbilical Cord Blood Market by Storage Service (Public Cord Blood Banks, Private Cord Blood Banks, and Hybrid Cord Blood Banks), Therapeutics (Cancer, Diabetes, Blood Diseases, Immune Disorders, Metabolic Disorders, and Other Diseases), and Application( Transplant Medicine and Regenerative Medicine): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,769.00
The global stem cell umbilical cord blood market was valued at $3,110.8 million in 2019, and is projected to reach $10,135.20 million by 2027, registering a CAGR of 16.9% from 2020 to 2027. Presently,...
August 2020
209 pages
Adalimumab - Biosimilars Insight, 2020
US$ 1,600.00
This report can be delivered to the clients within 72-96 hours DelveInsight’s, “Adalimumab – Biosimilar Insight, 2020,” report provides comprehensive insights about 35+ companies and 45+ marketed an...
August 2020
90 pages
Bevacizumab - Biosimilars Insight, 2020
US$ 1,600.00
This report can be delivered to the clients within 96-120 hours DelveInsight’s, “Bevacizumab– Biosimilar Insight, 2020,” report provides comprehensive insights about 40+ companies and 40+ marketed a...
August 2020
125 pages
Filgrastim - Biosimilar Insight, 2020
US$ 1,600.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Filgrastim– Biosimilar Insight, 2020,” report provides comprehensive insights about 20+ companies and 20+ marketed and...
August 2020
70 pages
Infliximab - Biosimilars Insight, 2020
US$ 1,600.00
This report can be delivered to the clients within 72-96 hours DelveInsight’s, “Infliximab– Biosimilar Insight, 2020,” report provides comprehensive insights about 35+ companies and 45+ marketed and...
August 2020
90 pages
Insulin Glargine- Biosimilar Insight, 2020
US$ 1,600.00
This report can be delivered to the clients within 72-96 hours DelveInsight’s, “Insulin Glargine– Biosimilar Insight, 2020,” report provides comprehensive insights about 10+ companies and 10+ market...
August 2020
90 pages
Interferon - Biosimilar Insight, 2020
US$ 800.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Interferon– Biosimilar Insight, 2020,” report provides comprehensive insights about 10+ companies and 10+ marketed and...
August 2020
70 pages
Ranibizumab - Biosimilars Insight, 2020
US$ 1,200.00
This report can be delivered to the clients within 72-96 hours DelveInsight’s, “Ranibizumab– Biosimilar Insight, 2020,” report provides comprehensive insights about 20+ companies and 20+ marketed an...
August 2020
90 pages
Rituximab - Biosimilars Insight, 2020
US$ 2,000.00
This report can be delivered to the clients within 96-120 hours DelveInsight’s, “Rituximab– Biosimilar Insight, 2020,” report provides comprehensive insights about 35+ companies and 35+ marketed and...
August 2020
125 pages
Somatotropin - Biosimilar Insight, 2020
US$ 800.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Somatropin – Biosimilar Insight, 2020,” report provides comprehensive insights about 10+ companies and 10+ marketed an...
August 2020
70 pages
Trastuzumab - Biosimilars Insight, 2020
US$ 2,000.00
This report can be delivered to the clients within 96-120 hours DelveInsight’s, “Trastuzumab– Biosimilar Insight, 2020,” report provides comprehensive insights about 35+ companies and 35+ marketed a...
August 2020
125 pages
Biometric-as-a-Service Market by Offering, Solution (Fingerprint Recognition, Iris Recognition, Voice Recognition, Palm & Vein Recognition), Trait (Physiological, Behavioral), Modality, Organization Size, Vertical, Region-Global Forecast to 2025
US$ 4,950.00
... (US). Research coverage The report segments the global biometric-as-a-service market by application area, modality, offering, and region. The application area segment comprises government and defense, financial ...
July 2020
210 pages
Biosimilars Market by Product (Insulin, rhGH, Granulocyte colony-stimulating factor, Interferon, Erythropoietin, Etanercept, Monoclonal antibodies, Follitropin, Glucagon, Calcitonin, Teriparatide, and Enoxaparin Sodium), By Manufacturing (In-house, Contract) & Indication (Offsite Treatment, Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease, Blood Disorders, Infectious Disease, and Other Diseases), By Geography (North America, Europe, APAC, and RoW) Global Opportunity Analysis and Industry Forecast up to 2026
US$ 3,250.00
Biosimilars Market by Product (Insulin, rhGH, Granulocyte colony-stimulating factor, Interferon, Erythropoietin, Etanercept, Monoclonal antibodies, Follitropin, Glucagon, Calcitonin, Teriparatide, and...
July 2020
85 pages
Nanotechnology Companies in China
US$ 1,800.00
This study focuses on China’s Nanotechnology industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
July 2020
53 pages
Nanotechnology Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Nanotechnology industry forecasts. In the two past decades, the ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
July 2020
91 pages
Nanotechnology Markets in China
US$ 4,000.00
China's demand for Nanotechnology has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
July 2020
206 pages
2020 Biomarin Performance, Capabilities, Goals and Strategies
US$ 750.00
... and Development, Technological Know-How, Key Products, Marketing Capabilities, Financial Results, Strengths and Weaknesses, and Strategic Direction. ... current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis its competitors. To assist potential market entrants ...
July 2020
2020 Biotechnology: Leading Companies Capabilities, Goals and Strategies
US$ 3,500.00
... capabilities in relation to the leading competitors. The series includes current assessments of more than 1,000 companies worldwide. Depending on the company’s ... effective marketing and R&D programs. In the dynamic and fragmented Biotechnology industry, besieged by intense competition and rapid change of ...
July 2020
2020 Generic Drugs: Leading Companies Capabilities, Goals and Strategies
US$ 3,500.00
... capabilities in relation to the leading competitors. The series includes current assessments of more than 1,000 companies worldwide. Depending on the company’s ... effective marketing and R&D programs. In the dynamic and fragmented generic drug industry, besieged by intense competition and rapid change of ...
July 2020
2020 Regeneron Performance, Capabilities, Goals and Strategies
US$ 750.00
... and Development, Technological Know-How, Key Products, Marketing Capabilities, Financial Results, Strengths and Weaknesses, and Strategic Direction. ... current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis its competitors. To assist potential market entrants ...
July 2020
2020 Seattle Genetics Performance, Capabilities, Goals and Strategies
US$ 750.00
... and Development, Technological Know-How, Key Products, Marketing Capabilities, Financial Results, Strengths and Weaknesses, and Strategic Direction. ... current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis its competitors. To assist potential market entrants ...
July 2020
2020 United Therapeutics Performance, Capabilities, Goals and Strategies
US$ 750.00
... and Development, Technological Know-How, Key Products, Marketing Capabilities, Financial Results, Strengths and Weaknesses, and Strategic Direction. ... current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis its competitors. To assist potential market entrants ...
July 2020
